AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle

• Published in: American journal of physiology: endocrinology and metabolism Vol. 46; no. 5; pp. E965 - E970
• Main Authors: OLSEN, Grith S, HANSEN, Bo F
• Format: Journal Article
• Language: English
• Published: Bethesda, MD American Physiological Society 01.11.2002
• Subjects: Biological and medical sciences; Body fat; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Glucose; Medical sciences; Metabolism; Rodents; Pancreatic hormone; Rat; Enzyme; Glycogen; Transferases; Rodentia; Lipids; Activation; Biosynthesis; Free fatty acid; Striated muscle; Insulin; Target tissue resistance; Vertebrata; Mammalia; Protein kinase; Animal; Extensor digitorum muscle
• ISSN: 0193-1849

We examined whether acute activation of 5'-AMP-activated protein kinase (AMPK) by 5'-aminoimidazole-4-carboxamide-1--D-ribonucleoside (AICAR) ameliorates insulin resistance in isolated rat skeletal muscle. Insulin resistance was induced in extensor digitorum longus (EDL) muscles by prolonged exposure to 1.6 mM palmitate, which inhibited insulin-stimulated glycogen synthesis to 51% of control after 5 h of incubation. Insulin-stimulated glucose transport was less affected (22% of control). The decrease in glycogen synthesis was accompanied by decreased glycogen synthase (GS) activity and increased GS phosphorylation. When including 2 mM AICAR in the last hour of the 5-h incubation with palmitate, the inhibitory effect of palmitate on insulin-stimulated glycogen synthesis and glucose transport was eliminated. This effect of AICAR was accompanied by activation of AMPK. Importantly, AMPK inhibition was able to prevent this effect. Neither treatment affected total glycogen content. However, glucose 6-phosphate was increased after inclusion of AICAR, indicating increased influx of glucose. No effect of AICAR on the inhibited insulin-stimulated GS activity or increased GS phosphorylation by palmitate could be detected. Thus the mechanism by which AMPK activation ameliorates the lipid-induced insulin resistance probably involves induction of compensatory mechanisms overriding the insulin resistance. Our results emphasize AMPK as a promising molecular target for treatment of insulin resistance.